Inhibitory Action of a Novel Proton Pump Inhibitor, Rabeprazole, and its Thioether Derivative Against the Growth and Motility of Clarithromycin‐Resistant <i>Helicobacter pylori</i>

Abstract

Rabeprazole-TH, which is secreted into the gastric mucosa, had the strongest inhibitory action against both the growth and motility of CRHP, suggesting that it is a potential novel agent for CRHP eradication.